Insider · CIK 0001535065
Kamdar Kim P.
Reports to the SEC for 20 companies · SALT LAKE CITY, UT
Transactions
50
Companies
20
Filings
8
CIK
0001535065
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-07-10 | SERASERA PROGNOSTICS, INC.A Award | — |
| 2026-07-10 | SERASERA PROGNOSTICS, INC.A Award | — |
| 2026-07-10 | SERASERA PROGNOSTICS, INC. · Stock Option (right to buy)A Award | — |
| 2026-07-10 | SERASERA PROGNOSTICS, INC. · Stock Option (right to buy)A Award | — |
| 2026-02-04 | SERASERA PROGNOSTICS, INC.J Other | — |
| 2026-02-04 | SERASERA PROGNOSTICS, INC.J Other | — |
| 2025-06-05 | SERASERA PROGNOSTICS, INC.A Award | — |
| 2025-06-05 | SERASERA PROGNOSTICS, INC. · Stock Option (right to buy)A Award | — |
| 2025-02-21 | Singular Genomics Systems, Inc.D Disposition to Issuer | — |
| 2025-02-21 | Singular Genomics Systems, Inc.D Disposition to Issuer | — |
| 2025-02-21 | Singular Genomics Systems, Inc.D Disposition to Issuer | — |
| 2025-02-21 | Singular Genomics Systems, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-21 | Singular Genomics Systems, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-21 | Singular Genomics Systems, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-21 | Singular Genomics Systems, Inc.Stock Option (Right to Buy)D Disposition to Issuer | −$21.8K |
| 2024-06-06 | SERASERA PROGNOSTICS, INC.A Award | — |
| 2024-06-06 | SERASERA PROGNOSTICS, INC. · Stock Option (right to buy)A Award | — |
| 2024-05-29 | Singular Genomics Systems, Inc.Stock Option (Right to Buy)A Award | — |
| 2023-12-21 | EVFMEvofem Biosciences, Inc.S Sale | −$6.21 |
| 2023-08-15 | Singular Genomics Systems, Inc.S Sale | −$107K |
| 2023-08-14 | Singular Genomics Systems, Inc.S Sale | −$44.4K |
| 2023-08-11 | Singular Genomics Systems, Inc.S Sale | −$211K |
| 2023-06-08 | SERASERA PROGNOSTICS, INC. · Stock Option (right to buy)A Award | — |
| 2023-05-25 | Singular Genomics Systems, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-06-03 | SERASERA PROGNOSTICS, INC. · Stock Option (right to buy)A Award | — |
| 2022-05-26 | Singular Genomics Systems, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-05-04 | EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2021-06-18 | EVFMEvofem Biosciences, Inc.P Purchase | +$11.7K |
| 2021-06-01 | Singular Genomics Systems, Inc.C Conversion | — |
| 2021-06-01 | Singular Genomics Systems, Inc.Series Seed Convertible Preferred StockC Conversion | — |
| 2021-06-01 | Singular Genomics Systems, Inc.Series A Convertible Preferred StockC Conversion | — |
| 2021-06-01 | Singular Genomics Systems, Inc.Series B Convertible Preferred StockC Conversion | — |
| 2021-05-12 | EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2020-09-16 | HINDVyome Holdings, Inc · Stock OptionA Award | — |
| 2020-09-16 | HINDVyome Holdings, Inc · Stock Option (Right to Buy)A Award | — |
| 2020-06-12 | EVFMEvofem Biosciences, Inc.P Purchase | +$14.7K |
| 2020-05-12 | EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2019-08-06 | HINDVyome Holdings, IncP Purchase | +$50K |
| 2019-08-06 | HINDVyome Holdings, Inc · Warrants to Purchase Common StockP Purchase | +$37.5K |
| 2019-07-23 | HINDVyome Holdings, IncA Award | — |
| 2019-06-05 | EVFMEvofem Biosciences, Inc. · Stock Option (Right to Buy)A Award | — |
| 2019-05-22 | EVFMEvofem Biosciences, Inc.J Other | — |
| 2019-05-21 | EVFMEvofem Biosciences, Inc.S Sale | −$3,320.85 |
| 2018-08-23 | HINDVyome Holdings, IncP Purchase | +$100K |
| 2018-06-13 | HINDVyome Holdings, Inc · Stock Option (Right to Buy)A Award | — |
| 2018-05-08 | EVFMEvofem Biosciences, Inc. · Stock Option (Right to Buy)A Award | — |
| 2017-06-20 | EVFMEvofem Biosciences, Inc. · Stock Option (Right to Buy)A Award | — |
| 2017-06-06 | HINDVyome Holdings, Inc · Stock Option (Right to Buy)A Award | — |
| 2017-05-11 | EVFMEvofem Biosciences, Inc. · Stock Option (Right to Buy)A Award | — |
| 2017-05-09 | HINDVyome Holdings, Inc · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Kamdar Kim P.0001535065-26-000002SEC(opens sec.gov)
- 4Kamdar Kim P.0001193125-26-037807SEC(opens sec.gov)
- 4Kamdar Kim P.0000950170-25-083335SEC(opens sec.gov)
- 4Kamdar Kim P.0000950170-25-027096SEC(opens sec.gov)
- 4Kamdar Kim P.0001534969-24-000133SEC(opens sec.gov)
- 4Kamdar Kim P.0000950170-24-067532SEC(opens sec.gov)
- 4Kamdar Kim P.0001493152-23-045912SEC(opens sec.gov)
- 4Kamdar Kim P.0001209191-23-045925SEC(opens sec.gov)
Companies
- ACHILLION PHARMACEUTICALS INC10% Owner
- aTYR PHARMA INC10% OwnerATYR
- Bionano Genomics, Inc.10% OwnerBNGO
- CADENCE PHARMACEUTICALS INC10% Owner
- Celator Pharmaceuticals Inc10% Owner
- Clovis Oncology, Inc.10% Owner
- Durata Therapeutics, Inc.10% Owner
- Esperion Therapeutics, Inc.10% OwnerESPR
- Evofem Biosciences, Inc.DirectorEVFM
- Evoke Pharma Inc10% OwnerEVOK
- GLAUKOS Corp10% OwnerGKOS
- MARINUS PHARMACEUTICALS, INC.10% Owner
- Ocera Therapeutics, Inc.10% Owner
- Orexigen Therapeutics, Inc.10% Owner
- SERA PROGNOSTICS, INC.DirectorSERA
- Singular Genomics Systems, Inc.Director
- Syndax Pharmaceuticals IncDirector, 10% OwnerSNDX
- Tobira Therapeutics, Inc.10% Owner
- Vyome Holdings, IncDirectorHIND
- ZOGENIX, INC.10% Owner
Address
C/O SERA PROGNOSTICS, INC. 2749 EAST PARLEYS WAY, SUITE 200
SALT LAKE CITY, UT, 84109